Therapeutic properties of mushrooms in managing adverse effects in the metabolic syndrome

Curr Top Med Chem. 2013;13(21):2734-44. doi: 10.2174/15680266113136660196.

Abstract

Metabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide fractions and isolated compounds possessed hypoglycaemic, cholesterol and triglyceride lowering ability, hypotensive effects, as well as weight managing activity by influencing satiety. The most active compounds are polysaccharides, called β-glucans, as well as lectines and small compounds such as eritadenin, triterpenes, sterols and phenolic compounds.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Agaricales / chemistry*
  • Agaricus / chemistry
  • Animals
  • Clinical Trials as Topic
  • Humans
  • Hyperglycemia / drug therapy
  • Hypertension / prevention & control
  • Hypoglycemic Agents / therapeutic use
  • Hypolipidemic Agents / pharmacology
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / diet therapy*
  • Metabolic Syndrome / drug therapy*
  • Obesity / prevention & control

Substances

  • Hypoglycemic Agents
  • Hypolipidemic Agents